| Pharmaceutical active ingredients: |
| Oxprenolol Hydrochloride |
| Available forms, composition and doses of Trasicor: |
| Capsules; Oral; Oxprenolol Hydrochloride 160 mgCapsules; Oral; Oxprenolol Hydrochloride 20 mgCapsules; Oral; Oxprenolol Hydrochloride 40 mgCapsules; Oral; Oxprenolol Hydrochloride 80 mgDragee, Retard; Oral; Oxprenolol Hydrochloride 80 mgTablets, Film-Coated; Oral; Oxprenolol Hydrochloride 40 mgTablets, Film-Coated; Oral; Oxprenolol Hydrochloride 80 mg |
| Trasicor medical category: |
| Human:Beta-adrenergic blocking agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C07AA02 - Oxprenolol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisAmdipharmSandozSanofi-Aventis |